Strength Training on GLP-1s

Strength training on GLP-1 medications can protect muscle mass and boost results. Learn what the research says and how to get started safely.

woman standing surrounded by exercise equipment

Key Takeaways

  • GLP-1 medications may reduce overall physical activity levels in some people, making intentional exercise even more important, according to a 2025 systematic review.
  • Resistance training is highlighted in recent research as a key strategy for preserving lean muscle mass and metabolic health during GLP-1-assisted weight loss.
  • Combining incretin-based therapy with a structured exercise program—sometimes called metabolic rehabilitation—may support more sustainable, long-term weight management.
  • Protecting muscle mass matters beyond appearance: muscle supports metabolism, joint health, heart function, and everyday physical independence.
  • Always consult a qualified healthcare professional before starting or changing any exercise program, especially while taking prescription medication.

Why does muscle mass matter when you’re losing weight on a GLP-1?

Muscle mass matters on a GLP-1 because these medications reduce overall body weight — but without the right support, a meaningful portion of that weight loss can come from muscle rather than fat alone. Protecting your muscle helps keep your metabolism running efficiently and supports long-term weight maintenance.

What “muscle mass” actually means here

Muscle mass refers to the amount of muscle tissue in your body. More muscle means your body burns more calories at rest — a measure called your resting metabolic rate. When you lose muscle alongside fat, that rate drops, making it harder to maintain weight loss over time.

The GLP-1 and muscle loss connection

GLP-1 medications work partly by reducing appetite, which means you eat less. Eating significantly less — especially less protein — can cause your body to break down muscle for energy. A narrative review on multimodal weight loss strategies notes that rapid caloric restriction without targeted nutritional support is a key driver of muscle loss during weight loss treatment.

Research focused on optimizing GLP-1 weight loss outcomes found that up to 25–39% of total weight lost during GLP-1 therapy can come from lean mass (muscle and other non-fat tissue) rather than fat — a proportion that matters for your health beyond the number on the scale.

Why losing muscle creates real problems

  • Slower metabolism: Less muscle means fewer calories burned at rest, which can make weight regain more likely if medication is stopped or reduced.
  • Weaker physical function: Muscle supports balance, mobility, and everyday strength. The same precision nutrition review highlights that preserving muscle function — not just body weight — is a core goal of sustainable treatment.
  • Joint and bone stress: A review on GLP-1s and knee osteoarthritis notes that maintaining muscle around joints helps protect them, particularly as body weight shifts during treatment.

The practical takeaway

Protecting muscle while on a GLP-1 requires intention but isn’t complicated. The multimodal strategy review identifies two evidence-supported priorities: eating enough protein and doing resistance exercise (such as bodyweight moves, bands, or weights). These two habits work together to signal your body to hold onto muscle even as overall weight comes down.

Talk with your healthcare provider or a registered dietitian about protein targets and an exercise plan that fits your current fitness level.


This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making changes to your medication, diet, or exercise routine.

Do GLP-1 medications affect how much you move day-to-day?

GLP-1 medications may modestly increase how much people move each day, but the effect is small and not guaranteed — what you do alongside the medication matters far more. Here’s what the research currently shows and what it means for you practically.


What the research found

A recent systematic review and meta-analysis examined whether GLP-1 receptor agonists (a class of medications that includes semaglutide and liraglutide) change objective physical activity — meaning movement measured by a device like a step counter or accelerometer, rather than self-reported estimates. Key findings:

  • Overall step counts and activity levels increased slightly in people taking GLP-1 medications compared to those not taking them, but the increases were modest.
  • The effect varied considerably between studies, meaning some people moved noticeably more, while others showed little change.
  • The researchers described the evidence as exploratory, so it’s too early to say GLP-1 medications reliably increase movement on their own.

Why movement might increase — or not

Several factors may explain why some people move more while on these medications:

  • Less joint pain. GLP-1 medications reduce body weight, which decreases pressure on the knees and hips. Research on knee osteoarthritis suggests this pain relief may make activity easier (GLP-1 and knee osteoarthritis).
  • More energy. Some people report feeling better overall, which may translate into increased day-to-day movement (patient-reported outcomes study).
  • The medication alone isn’t enough. Experts consistently note that structured exercise must be added deliberately — it doesn’t occur simply as a side effect of taking the medication (multimodal strategy review).

Why adding intentional movement still matters

Even if you move somewhat more naturally, planned physical activity — especially resistance training (exercises that work your muscles against weight or resistance) — provides benefits the medication cannot. GLP-1-related weight loss can include muscle loss, and resistance training helps preserve muscle (precision nutrition and resistance training). Preserving muscle supports your metabolism and long-term health.


The bottom line for you

Don’t rely on the medication to increase your activity automatically. Treat any extra movement as a bonus — then build intentional activity on top of it, ideally with guidance from your care team.


This content is for general informational purposes only and is not medical advice. Always consult a qualified healthcare professional before making any changes to your treatment, exercise routine, or lifestyle.

What does the research say about resistance training and GLP-1s?

Research consistently shows that adding resistance training (also called strength training—exercises that work your muscles against a force, like weights or resistance bands) while taking a GLP-1 medication helps protect muscle mass that might otherwise be lost alongside body fat. In plain terms: the medication helps you lose weight, and resistance training helps ensure more of that weight comes from fat rather than muscle.

Here’s what the evidence tells us:

-Muscle loss is a real concern with GLP-1s. When people lose weight quickly—whether through medication, diet, or surgery—the body doesn’t always shed fat alone. A meaningful portion of the weight lost can come from muscle. Preserving muscle matters because it supports your strength, balance, metabolism, and long-term health. A 2025 review in Optimizing Weight Loss in the GLP-1 Era (source) identifies resistance training as a key strategy for protecting muscle mass and function during GLP-1-assisted weight loss.

  • Combining GLP-1s with resistance training may produce better body composition outcomes than medication alone. Body composition—the ratio of fat to muscle in your body—is an important marker of health. The same review found that pairing precision nutrition and resistance training with GLP-1 therapy supports metabolic health beyond what the medication achieves on its own.

  • GLP-1s may modestly increase overall physical activity levels. A 2025 systematic review and meta-analysis found that GLP-1 receptor agonists had a small positive effect on objective physical activity in adults. This suggests the medications may make it somewhat easier to move more, which could support an exercise routine, though the effect was modest and more research is needed.

  • A multimodal approach—medication plus exercise plus nutrition—is emerging as the recommended standard. A 2025 narrative review on metabolic rehabilitation concluded that combining incretin-based therapy (the drug class GLP-1s belong to) with structured exercise and dietary support produces more sustainable weight loss than any single strategy alone.

The bottom line: GLP-1 medications are a powerful tool, but resistance training appears to be an important partner—helping you retain the muscle that keeps you strong, functional, and metabolically healthy as the weight comes off.


This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider before starting or changing any exercise program or medication.

How does exercise support heart and joint health alongside GLP-1 therapy?

Exercise works alongside GLP-1 medications to protect your heart and joints in ways the medication alone cannot — and the combination appears more effective than either approach on its own.

How exercise supports your heart

GLP-1 medications reduce body weight and improve some heart-related markers, but regular physical activity adds benefits beyond what the scale shows. Research on incretin-based therapies found improvements in heart function, inflammation, and blood pressure — with stronger effects when lifestyle changes, including exercise, were included (systematic review, PMID 42382865). Structured physical activity directly lowers cardiovascular risk factors such as high blood pressure and poor cholesterol levels (lifestyle review, PMID 42402270).

  • Aerobic exercise (walking, cycling, swimming) strengthens the heart muscle and improves pumping efficiency.
  • Resistance training (weights, resistance bands) preserves muscle mass — important because GLP-1-related weight loss can reduce muscle alongside fat (nutrition and training review, PMID 42356514).

How exercise supports your joints

Weight loss reduces load on your knees, hips, and ankles — and GLP-1 medications help achieve this. Exercise adds additional benefit. Research on knee osteoarthritis found that GLP-1 therapy combined with physical activity reduced joint pain and improved function more than weight loss alone (knee osteoarthritis review, PMID 42389272). Strengthening muscles around a joint stabilizes it and relieves pressure on cartilage.

An important consideration: GLP-1s may affect activity levels

Some research suggests GLP-1 medications may modestly reduce overall physical activity in some people — possibly because appetite changes also affect energy and motivation (physical activity meta-analysis, PMID 42399550). This makes intentional, structured exercise more important than relying on spontaneous movement. A multimodal approach combining medication, structured exercise, and nutrition is consistently described as the most sustainable path (metabolic rehabilitation review, PMID 42365122).


This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any exercise or medication plan.

What does a ‘metabolic rehabilitation’ approach actually look like?

Metabolic rehabilitation is a structured, team-based program that pairs GLP-1 medication with targeted nutrition, exercise, and behavioral support to help your body lose fat while preserving muscle and improving long-term health. The medication is one tool in a larger toolkit, not the entire plan.

According to a narrative review on multimodal obesity therapy, this combined approach addresses the underlying drivers of weight gain—not just the number on the scale. Here’s what it typically includes:

Nutrition support focused on protein and food quality

A registered dietitian helps you meet a higher protein target (often around 1.2–1.6 grams per kilogram of body weight per day) to protect muscle during weight loss, as outlined in research on precision nutrition with GLP-1s. Meals center on whole foods that sustain fullness and steady energy—particularly important because GLP-1 medications reduce appetite, making it easy to under-eat without realizing it.

Resistance training

Lifting weights or doing bodyweight exercises at least 2–3 times per week is core to the plan. Research on muscle preservation during GLP-1 therapy shows that without resistance training, a meaningful portion of weight lost comes from muscle rather than fat, which weakens the body and slows metabolism over time. A physical therapist or certified trainer can design a program matched to your current fitness level and any joint concerns.

Gradual increase in daily movement

Beyond structured workouts, the goal is moving more throughout the day. A systematic review of physical activity and GLP-1 medications found that people on these medications tend to increase their activity levels naturally, and building on that momentum matters.

Behavioral and psychological support

A counselor or health coach helps you address eating habits, stress responses, and your emotional relationship with food. Cross-sectional research on patient satisfaction with incretin therapies found that people who felt supported beyond medication alone reported better outcomes and higher satisfaction with their care.

Care coordination across providers

The multimodal strategy review emphasizes that these components work best when your prescriber, dietitian, and exercise professional communicate—allowing your plan to adjust as your body changes.


This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making changes to your medication, diet, or exercise routine.

How do you get started with strength training safely on a GLP-1?

Starting strength training while on a GLP-1 medication is doable and worthwhile — but the key is beginning gradually, eating enough protein, and checking in with your healthcare provider first. Here’s what the evidence suggests.

Why it matters on a GLP-1

GLP-1 medications reduce appetite, which is the goal — but eating less also means you may consume less protein, the building block your muscles need to stay strong. Research shows that without resistance training, a meaningful portion of weight lost on these medications can come from muscle, not just fat. A 2025 review in Obesity found that combining resistance training with GLP-1 therapy is one of the most effective strategies for preserving muscle mass and maintaining a healthy metabolism during weight loss.

How to get started safely

  • Talk to your provider first. Before starting any new exercise program, inform your doctor or care team — especially if you have joint pain, heart conditions, or other health concerns. A narrative review on metabolic rehabilitation emphasizes that exercise should be part of a supervised, individualized plan.

  • Start with two sessions per week. Two to three sessions of 20–30 minutes is a reasonable starting point. The same Obesity review recommends progressive resistance training — gradually increasing the challenge over time — as the standard for protecting muscle on a GLP-1.

  • Choose beginner-friendly movements. Bodyweight squats, wall push-ups, seated leg presses, and resistance band rows are low-impact options that build strength without overwhelming your joints. If you experience knee discomfort — common during weight loss — a review on GLP-1s and knee osteoarthritis notes that reducing joint load through gradual exercise is part of a sound therapeutic approach.

  • Prioritize protein at every meal. The Obesity review highlights adequate protein intake — generally 1.2–1.6 grams per kilogram of body weight per day — as essential alongside resistance training to maintain muscle. Ask your provider or a registered dietitian what target is right for you.

-Rest and recover. Allow at least one rest day between strength sessions. Fatigue and reduced appetite on GLP-1s can affect your energy, so listen to your body.

Progress will likely feel slow at first — that’s normal and healthy. Consistency over weeks matters far more than intensity on any single day.


This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting a new exercise program.

FAQ

Can I lose muscle mass while taking a GLP-1 medication?

Research suggests that weight loss from any cause—including GLP-1 therapy—can include loss of lean muscle mass alongside fat. A 2025 review in Pharmaceuticals noted this as a key concern and highlighted resistance training and adequate protein intake as strategies to help preserve muscle. Talk to your doctor or a registered dietitian about your individual situation.

Will a GLP-1 medication make me less motivated to exercise?

A 2025 systematic review and exploratory meta-analysis in the International Journal of Obesity found that GLP-1 receptor agonists did not consistently increase objective physical activity levels in adults, and some analyses suggested activity may decrease. This underscores why building a deliberate exercise habit is important—don’t rely on the medication alone to keep you moving.

General public health guidelines typically suggest muscle-strengthening activities on two or more days per week. Still, the right amount for you depends on your current fitness level, health conditions, and goals. A 2025 narrative review in the International Journal of Obesity recommended integrating resistance training as part of a multimodal strategy alongside GLP-1 therapy. Ask your healthcare team for personalized guidance.

Does exercise help with the joint pain that can come with obesity?

A 2025 review in Frontiers in Pharmacology on GLP-1s and obesity-related knee osteoarthritis noted that weight reduction can reduce mechanical load on joints. Exercise plays a role in the broader therapeutic pathway for joint health. Strength training that supports the muscles around joints may be particularly beneficial, but always check with your provider before starting if you have joint concerns.

Can exercise improve heart health outcomes for people on GLP-1 therapy?

A 2025 systematic review in Cureus examining GLP-1 therapies and heart failure with preserved ejection fraction noted that lifestyle factors including physical activity are part of a comprehensive cardiometabolic management approach. A 2025 Journal of Cardiology review on atrial fibrillation also emphasized exercise as a cornerstone of lifestyle intervention for cardiovascular risk. Your cardiologist or primary care provider can advise on safe exercise for your heart health.

Does how I feel on a GLP-1 medication affect whether I exercise?

A 2025 cross-sectional study in Frontiers in Endocrinology found that patient-reported outcomes and treatment satisfaction with incretin-based therapies were influenced by factors beyond weight loss alone—suggesting that overall wellbeing, energy, and quality of life matter. If side effects or low energy are making it hard to exercise, discuss this with your prescribing provider.

This article is for general information and is not medical advice. GLP-1 medications are prescription drugs that require clinical supervision — talk to a licensed healthcare provider before starting, stopping, or changing any treatment.

Sources

  1. Total care strategies in atrial fibrillation practice: Lifestyle intervention and risk factor management.
  2. The impact of glucagon-like peptide-1 receptor agonists on objective physical activity in adults: a systematic review and exploratory meta-analysis.
  3. GLP-1 receptor agonists in obesity-related knee osteoarthritis: from weight loss to therapeutic pathway reconstruction.
  4. Beyond weight loss: predictors of treatment satisfaction and patient-reported outcomes in incretin-based therapies. A cross-sectional study.
  5. Incretin-Based Therapies in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF): A Systematic Review of Emerging Cardiometabolic Disease Modification Beyond Glycemic Control.
  6. Integrating metabolic rehabilitation with incretin-based anti-obesity therapy: a narrative review of a multimodal strategy for sustainable weight loss.
  7. Optimizing Weight Loss in the GLP-1 Era: Preserving Muscle Mass, Function and Metabolic Health Through Precision Nutrition and Resistance Training.